Surveillance of adverse drug events associated with tocilizumab in hospitalized veterans with coronavirus disease 2019 (COVID-19) to inform patient safety and pandemic preparedness. uri icon

authors

  • Rupak Datta, MD PhD
  • Barrett, Alexis
  • Burk, Muriel
  • Salone, Cedric
  • Au, Anthony
  • Cunningham, Francesca
  • Fisher, Ann
  • Dembry, Louise Marie
  • Akgün, Kathleen M

publication date

  • January 1, 2021